Design and analysis heterogeneity in observational studies of COVID-19 booster effectiveness: A review and case study

S Meah, X Shi, LG Fritsche, M Salvatore, A Wagner… - Science …, 2023 - science.org
We investigated the design and analysis of observational booster vaccine effectiveness (VE)
studies by performing a scoping review of booster VE literature with a focus on study design …

Impact of COVID-19 on Pediatric Inflammatory Bowel Diseases—From Expectations to Reality

LM Trandafir, EL Spoiala, G Ghiga, N Gimiga… - Journal of Personalized …, 2024 - mdpi.com
Viral infections have always been considered a threat to global health, with numerous
outbreaks across time. Despite the relative recent experience with coronavirus-associated …

Increased risk of herpes zoster in adult patients with inflammatory bowel disease after SARS-CoV2 infection: a propensity-matched cohort study

A Desai, A Soni, MS Hayney… - Inflammatory Bowel …, 2023 - academic.oup.com
Background There is evidence that SARS-CoV2 infection can increase the risk of herpes
zoster (HZ) in the general population. However, the risk in patients with inflammatory bowel …

[HTML][HTML] A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy

TL Schell, F Caldera - Gastroenterology & Hepatology, 2024 - ncbi.nlm.nih.gov
The COVID-19 pandemic introduced significant uncertainty regarding the care of patients
with inflammatory bowel disease (IBD). Substantial research efforts have made progress in …

Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure prophylaxis for COVID-19 in patients with inflammatory bowel disease: a propensity matched cohort study

A Desai, JG Hashash, GS Kochhar… - Crohn's & Colitis …, 2023 - academic.oup.com
Abstract Background Tixagevimab and cilgavimab (Evusheld) are 2 fully human monoclonal
antibodies that received emergency-use authorization on December 21, 2021, for pre …

Additional COVID-19 booster doses increase anti-spike serum antibody concentrations among patients with inflammatory bowel disease

TL Schell, O Ramirez, M Almasry… - Inflammatory Bowel …, 2023 - academic.oup.com
To the Editors, It was with great interest that we read “Effect of 2 vs 3 Doses of COVID-19
Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity …

Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study

JC Petrov, AA Desai, GS Kochhar… - Inflammatory Bowel …, 2024 - academic.oup.com
Background Metformin exerts anti-inflammatory properties through a positive effect on
oxidative stress, gut barrier integrity, and the gut microbiota. Our aim was to evaluate the …

Impact of the COVID-19 Pandemic on the Diagnostic Frequency and Medical Therapies Applied to Subjects With Functional Seizures

G Schaefer Bennett, S Naik… - The Neurohospitalist, 2024 - journals.sagepub.com
Background and Purposes The coronavirus 2019 (COVID-19) pandemic was associated
with catastrophic consequences and increased psychological distress. However, it is …

[PDF][PDF] Uptake Rates of Three COVID-19 Vaccine Doses and Risk Factors for Incomplete Vaccination Among Patients With Inflammatory Bowel Disease Residing in …

TL Schell, MA Mailig, M Almasry, S Lazarus… - … : Official Publication of …, 2023 - wmjonline.org
Introduction: Patients with inflammatory bowel disease on systemic corticosteroids may be at
higher risk of adverse outcomes of COVID-19 infection, and vaccination is an essential …

COVID-19 aus Sicht der Gastroenterologie

K Schütte, C Schulz - Die Gastroenterologie, 2023 - Springer
Zusammenfassung Hintergrund Die Pandemie durch das Sars-CoV2-Virus (COVID-19) hat
die (medizinische) Welt verändert und in zahlreichen Facetten auch Einfluss auf die …